UK markets closed

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.67+0.35 (+3.76%)
As of 11:30AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
93,197
86,140
82,274
51,100
13,704
Selling general and administrative
16,501
18,821
24,714
20,391
7,824
Total operating expenses
109,698
104,961
106,988
71,491
21,528
Operating income or loss
-109,698
-104,961
-106,988
-71,491
-21,528
Interest expense
-
-
-
0
653
Total other income/expenses net
-13
-19
-27
-47
-
Income before tax
-99,339
-96,655
-104,787
-71,096
-22,121
Income from continuing operations
-99,339
-96,655
-104,787
-71,096
-22,121
Net income
-99,339
-96,655
-104,787
-71,096
-22,121
Net income available to common shareholders
-99,339
-96,655
-104,787
-71,096
-23,990
Basic EPS
-2.31
-
-2.62
-1.80
-3.42
Diluted EPS
-2.31
-
-2.62
-1.80
-3.42
Basic average shares
41,548
-
39,995
39,524
7,021
Diluted average shares
41,548
-
39,995
39,524
7,021